Gaithersburg, MD, United States of America

Taylor Cohen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Medimmune Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taylor Cohen. Retrieved from https://idiyas.com/inventor/taylor-cohen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Taylor Cohen - Innovator in Antibody Combinations

Introduction

Taylor Cohen is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody combinations for medical applications. His innovative work focuses on treating and preventing infections through advanced antibody therapies.

Latest Patents

Taylor Cohen holds 1 patent related to his research. His patent, titled "Combinations of anti-antibodies," is directed towards anti-antibody combinations that include antibodies binding to alpha toxin (AT) protein, clumping factor A protein (ClfA), and at least one leukotoxin protein. The patent also outlines methods for treating and preventing infections by administering these antibody combinations.

Career Highlights

Cohen is currently employed at MedImmune Limited, a leading biotechnology company known for its focus on innovative therapies. His work at MedImmune has allowed him to collaborate with other talented professionals in the field, contributing to the advancement of medical science.

Collaborations

Throughout his career, Taylor Cohen has worked alongside notable colleagues such as Christine Tkaczyk and Bret Sellman. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Taylor Cohen's contributions to the field of antibody research exemplify the impact of innovative thinking in biotechnology. His work continues to pave the way for new treatments and therapies that can significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…